Overview Phase II Study of KWA-0711 in Patients With Chronic Constipation (CC) Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the safety and efficacy of KWA-0711 in Chronic Constipation (CC) patients. Phase: Phase 2 Details Lead Sponsor: Kissei Pharmaceutical Co., Ltd.